Is your patent adequately protected in all of the markets where you do business? Are you sure about that?
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, Intellectual Property Attorney, with JD - Lowrie Lando & Anastasi LLP and airs on Tuesday, March 24, 2009. For more details or to register for this conference, please visit our site www.fxconferences.com
Showing posts with label PhD. Show all posts
Showing posts with label PhD. Show all posts
Monday, March 16, 2009
Tuesday, December 9, 2008
Effective Licensing in the Wake of MedImmune v. Genentech
The licensing of life science technologies, especially oncology-related technologies, is becoming an essential part of doing business. With MedImmune v. Genentech, the United States Supreme Court transformed the relationship between patent licensors and licensees. Historically, licensees were prevented from challenging patents on invalidity grounds. Now, a licensee may challenge a patent's validity while paying royalties to the licensor.
Although framed as a procedural question of standing to bring suit, the application of this Supreme Court case has the potential to shift the decision making of licensors and licensees and to significantly change the volume and cost of patent licensing activities. In this audio conference Dr. Samardija explores the Supreme Court decision and the various decisions that have followed, and provides attendees with 10 drafting tips to decrease the risks associated with a licensee challenging the validity of a patent.
Effective Licensing in the Wake of MedImmune v. Genentech is being presented by Michael R. Samardzija, PhD, with Bracewell & Giuliani and airs on Thursday, January 29, 2009. For more details, or to register for this conference please visit our web site at www.fxconferences.com
Although framed as a procedural question of standing to bring suit, the application of this Supreme Court case has the potential to shift the decision making of licensors and licensees and to significantly change the volume and cost of patent licensing activities. In this audio conference Dr. Samardija explores the Supreme Court decision and the various decisions that have followed, and provides attendees with 10 drafting tips to decrease the risks associated with a licensee challenging the validity of a patent.
Effective Licensing in the Wake of MedImmune v. Genentech is being presented by Michael R. Samardzija, PhD, with Bracewell & Giuliani and airs on Thursday, January 29, 2009. For more details, or to register for this conference please visit our web site at www.fxconferences.com
Monday, December 8, 2008
Global Patent Standards
Is your patent adequately protected in all of the markets where you do business? Are you sure about that?
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, JD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs on Thursday, January 15, 2009. For more details or to register for this event, please visit our site www.fxconferences.com
In many industries, patent protection in both the United States and abroad is critical, but the requirements for each country are not necessarily the same. Thus, in developing a patent strategy, the different requirements of countries where protection is desired must be considered prior to filing.
In this audio conference, we review the various global patent standards in countries where patent protection is typically sought. Particular emphasis will be placed on written description requirements, obviousness and inventive step standards in the United States and in Europe.
Global Patent Standards is being presented by Christopher Rhodes, PhD, JD, Intellectual Property Attorney, with Lowrie Lando & Anastasi LLP and airs on Thursday, January 15, 2009. For more details or to register for this event, please visit our site www.fxconferences.com
Subscribe to:
Posts (Atom)